TAFAMIDIS News
TAFAMIDIS currently has 0 news articles, with 14 predicted indications.
This page combines the AI-predicted indications for TAFAMIDIS with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (14):
- ATTRV122I amyloidosis (99.0%)
- AH amyloidosis (99.0%)
- AL amyloidosis (99.0%)
- amyloidosis (disease) (99.0%)
- primary release disorder of platelets (89.3%)
- thrombocytopenic purpura (88.7%)
- pseudo-von Willebrand disease (87.9%)
- Glanzmann thrombasthenia (85.8%)
- primary amyloidosis (85.0%)
- acquired amyloid peripheral neuropathy (84.8%)
- primary hyperoxaluria (84.3%)
- dermis disease (83.4%)
- biotin metabolic disease (83.3%)
- mixed-type autoimmune hemolytic anemia (82.3%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.